TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2015

Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer: Results from the Phase II BASALT-1 Study.

Johan F Vansteenkiste et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.